Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trial

International Journal of Stroke, Ahead of Print. Background:Anti-inflammatory therapy using colchicine has reduced recurrent vascular events in patients with coronary heart disease.Design:Colchicine in High-risk Patients with Acute Minor-to-moderate Is…